Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 200 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA077816
NCI NIH HHS
Grant: R01 CA121192
NCI NIH HHS
Grant: T32 CA070085
National Institutes of Health
Grant: 5T32CA070085-08
Training Program in Signal Transduction and Cancer
National Institutes of Health
Grant: 2R01CA121192-06
Arsenic Trioxide activated pathways in malignant cells
National Institutes of Health
Grant: 5R01CA077816-12
Signal Transduction of Type I Interferons in Malignant Cells
FWCI
6.99
Citation Percentile
1.0%
Influential Citations
8
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19
Additional file 1 of Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways